These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 329053)
1. The neurological manifestations of porphyria: a review. Becker DM; Kramer S Medicine (Baltimore); 1977 Sep; 56(5):411-23. PubMed ID: 329053 [TBL] [Abstract][Full Text] [Related]
2. Respiratory insufficiency associated with acute hepatic porphyria. Wongthim S; Hemachudha T; Punthumchinda K J Med Assoc Thai; 1989 Nov; 72(11):655-9. PubMed ID: 2635211 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of acute porphyria. Yeung Laiwah AC; Moore MR; Goldberg A Q J Med; 1987 May; 63(241):377-92. PubMed ID: 3310073 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of neural manifestations in acute porphyria. Shanley BC; Percy VA; Neethling AC S Afr Med J; 1977 Apr; 51(14):458-60. PubMed ID: 870989 [TBL] [Abstract][Full Text] [Related]
6. Clinical Guide and Update on Porphyrias. Stölzel U; Doss MO; Schuppan D Gastroenterology; 2019 Aug; 157(2):365-381.e4. PubMed ID: 31085196 [TBL] [Abstract][Full Text] [Related]
7. "Glucose effect" and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias. Doss M; Sixel-Dietrich F; Verspohl F J Clin Chem Clin Biochem; 1985 Sep; 23(9):505-13. PubMed ID: 4067519 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and treatment of acute intermittent porphyria: discussion paper. Laiwah AC; Goldberg A; Moore MR J R Soc Med; 1983 May; 76(5):386-92. PubMed ID: 6864706 [No Abstract] [Full Text] [Related]
10. Hepatic porphyrias. Current concepts. Walsh JR Postgrad Med; 1977 Aug; 62(2):71-81. PubMed ID: 329249 [TBL] [Abstract][Full Text] [Related]
11. The hepatic porphyrias. Romeo G Prog Med Genet; 1980; 4():169-97. PubMed ID: 7003654 [No Abstract] [Full Text] [Related]
12. [Acute intermittent porphyria]. Catania A; Caimi G Minerva Med; 1983 Nov; 74(43):2605-9. PubMed ID: 6657112 [TBL] [Abstract][Full Text] [Related]
13. The neurologic manifestations of the acute porphyrias. Simon NG; Herkes GK J Clin Neurosci; 2011 Sep; 18(9):1147-53. PubMed ID: 21724399 [TBL] [Abstract][Full Text] [Related]
14. Acute intermittent porphyria: clinical and selected research aspects. Tschudy DP; Valsamis M; Magnussen CR Ann Intern Med; 1975 Dec; 83(6):851-64. PubMed ID: 1106284 [TBL] [Abstract][Full Text] [Related]
16. [Metabolic fate of porphyrin and its precursors in porphyria and porphyrinuria]. Harada K; Ohmori S; Kim Y; Tomokuni K Nihon Rinsho; 1995 Jun; 53(6):1349-56. PubMed ID: 7616646 [TBL] [Abstract][Full Text] [Related]
17. Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria. Anderson KE; Alvares AP; Sassa S; Kappas A Clin Pharmacol Ther; 1976 Jan; 19(1):47-54. PubMed ID: 1245093 [TBL] [Abstract][Full Text] [Related]
18. The hepatic porphyrias: pathogenesis, manifestations, and management. Bloomer JR Gastroenterology; 1976 Oct; 71(4):689-701. PubMed ID: 955357 [No Abstract] [Full Text] [Related]
19. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria. Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305 [TBL] [Abstract][Full Text] [Related]